Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia

被引：0
|
作者：
Khoury, H [1 ]
Adkins, D [1 ]
Zehnbauer, B [1 ]
Goodnough, L [1 ]
Brown, R [1 ]
Safdar, S [1 ]
DiPersio, JF [1 ]
机构：
[1] Washington Univ, Sch Med, Div Bone Marrow Transplantat & Stem Cell Biol, St Louis, MO 63110 USA
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 22卷 / 01期
关键词：
essential thrombocythemia; marrow transplantation; long-term complication;
D O I：
10.1038/sj.bmt.1701292
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Allogeneic transplant recipients are at high risk of developing secondary malignancies as a late complication of therapy. We report a case of essential thrombocythemia occurring 8 years following bone marrow transplantation (BMT) for chronic myelogenous leukemia.
引用
收藏
页码：107 / 109
页数：3
相关论文
共 50 条
  • [21] Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemia
    Kumar, S
    Litzow, MR
    Rajkumar, SV
    BONE MARROW TRANSPLANTATION, 2003, 32 (11) : 1065 - 1069
  • [22] Targeted Agents for Chronic Myelogenous Leukemia: Will That Be the End of Allogeneic Bone Marrow Transplantation for That Disease?
    Liang, Yuzhen
    Lai, Yongrong
    Schwarzenberger, Paul
    Li, Qiaochuan
    Ma, Jie
    Luo, Jun
    Liu, Rongrong
    Shi, Lingling
    Zhou, Jicheng
    Peng, Zhigang
    Yang, Jie
    Deng, Donghong
    Zhou, Yizhen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (06) : 848 - 853
  • [23] Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemia
    S Kumar
    M R Litzow
    S V Rajkumar
    Bone Marrow Transplantation, 2003, 32 : 1065 - 1069
  • [24] Resolution of atopic dermatitis following allogeneic bone marrow transplantation for chronic myelogenous leukemia
    Koharazawa, H
    Kanamori, H
    Takabayashi, M
    Yamaji, S
    Taguchi, J
    Fujimaki, K
    Ishigatsubo, Y
    BONE MARROW TRANSPLANTATION, 2005, 35 (12) : 1223 - 1224
  • [25] Allogeneic bone marrow transplantation in children with philadelphia positive chronic myelogenous leukemia.
    Sharathkumar, A
    Saunders, EF
    Calderwood, S
    Doyle, J
    Freedman, MH
    BLOOD, 1999, 94 (10) : 350A - 350A
  • [26] Bone marrow reconstitution with normal autologous cells demonstrated by VNTR analysis after allogeneic bone marrow transplantation for chronic myelogenous leukemia
    Uriarte, MD
    Bonomi, R
    Azambuja, C
    Seuánez, HN
    LEUKEMIA, 1997, 11 (12) : 2213 - 2214
  • [27] ALLOGENEIC MARROW TRANSPLANTATION FOR CHILDREN WITH JUVENILE CHRONIC MYELOGENOUS LEUKEMIA
    SANDERS, JE
    BUCKNER, CD
    THOMAS, ED
    FLEISCHER, R
    SULLIVAN, KM
    APPELBAUM, FA
    STORB, R
    BLOOD, 1988, 71 (04) : 1144 - 1146
  • [28] IMMUNOLOGICAL RECONSTITUTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION OF PATIENTS WITH MYELOGENOUS LEUKEMIA
    SAAL, JG
    SCHNEIDER, F
    SCHNEIDER, M
    SCHMIDT, H
    DOPFER, R
    EHNINGER, G
    BLUT, 1987, 55 (04): : 382 - 382
  • [29] BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    LITZOW, MR
    TEFFERI, A
    BLOOD, 1994, 83 (09) : 2752 - 2752
  • [30] Treatment of chronic myelogenous leukemia (CML) with allogeneic bone marrow transplantation after preparation with BuCy2.
    Copelan, EA
    Biggs, JC
    Szer, J
    Crilley, P
    Atkinson, K
    Avalos, B
    Topolsky, D
    Penza, SL
    Elder, PJ
    Bulova, SL
    Brodsky, I
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 670 - 670
12345